We are live on
!
Find out more
YCM
Yiheng Capital Management Portfolio holdings
AUM
$291M
1-Year Est. Return
19.43%
This Fund
S&P 500
This Quarter
Est. Return
+5.03%
1 Year Est. Return
+19.43%
3 Year Est. Return
+81.96%
5 Year Est. Return
+61.91%
10 Year Est. Return
+930.57%
AUM
$291M
AUM Growth
+$60.6M
(+26%)
Cap. Flow
+$779K
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
73.97%
Holding
29
New
5
Increased
5
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bilibili
BILI
|
+$15.2M |
| 2 |
PSIX
Power Solutions International
PSIX
|
+$7.34M |
| 3 |
Viridian Therapeutics
VRDN
|
+$3.09M |
| 4 |
BIOA
BioAge Labs
BIOA
|
+$3.08M |
| 5 |
ZEPP
Zepp Health
ZEPP
|
+$1.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
New Oriental
EDU
|
+$19.1M |
| 2 |
HNGE
Hinge Health
HNGE
|
+$7.64M |
| 3 |
SVCO
Silvaco Group
SVCO
|
+$1.97M |
| 4 |
Kymera Therapeutics
KYMR
|
+$859K |
| 5 |
Cellebrite
CLBT
|
+$634K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.04% |
| 2 | Miscellaneous | 19.48% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Healthcare | 12.26% |
| 5 | Technology | 11.43% |
Similar funds
TWA
SA
FDDB
NTIC
HMP
IAM
BCM
MPPHD
Yiheng Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Yiheng Capital Management held 29 positions worth $291M, up 26% from $231M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Yiheng Capital Management's Q2 2026 filing shows 5 new, 5 increased, 5 reduced and 1 closed positions. Its largest new stake was Power Solutions International: 133,500 shares worth $5.19M. The largest sale was New Oriental, an estimated $19.1M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 29% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
- Yiheng Capital Management's largest Q2 2026 buy was Power Solutions International: 133,500 shares worth $5.19M.
- Yiheng Capital Management added most to Bilibili in Q2 2026, an estimated $15.2M increase.
- Yiheng Capital Management's biggest Q2 2026 reduction was New Oriental, cutting an estimated $19.1M.
- Yiheng Capital Management fully exited Cellebrite in Q2 2026, selling an estimated $634K.
- Yiheng Capital Management's ten largest holdings make up 74% of its $291M portfolio in Q2 2026.
- Yiheng Capital Management opened 5 new positions and closed 1 in Q2 2026.
- Yiheng Capital Management's portfolio value rose 26% quarter-over-quarter to $291M.
Based on Yiheng Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.